Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/13/2012 | EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa |
06/13/2012 | EP0451216B2 Humanized immunoglobulins and their production and use |
06/13/2012 | CN1889970B Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication |
06/13/2012 | CN1759122B Methods and compositions involving MDA-7 |
06/13/2012 | CN1606567B Antimicrobial polypeptides from pseudoplectania nigrella |
06/13/2012 | CN1483831B Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges |
06/13/2012 | CN102498127A Peptides for the treatment of oxidative stress related disorders |
06/13/2012 | CN102497885A Use of interleukin-1 beta mutein conjugates in the treatment of diabetes |
06/13/2012 | CN102497878A Chemical method for sexual sterilisation and libido suppression in male mammals |
06/13/2012 | CN102497877A Modified erythropoietin to which water-soluble long-chain molecule is added |
06/13/2012 | CN102497876A Method for repairing neurodegeneration |
06/13/2012 | CN102497875A Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions |
06/13/2012 | CN102497779A Nutritional supplement |
06/13/2012 | CN102492761A Method for preparing active polypeptide from fish pomace |
06/13/2012 | CN102492670A Phosphatidylethanolamine-superoxide dismutase composition and preparation method thereof |
06/13/2012 | CN102492043A Anti-tumor and thrombolytic dual-effect chimeric protein with low immunogenicity, its preparation method and application |
06/13/2012 | CN102492034A Rice field eel serum transferrin, preparation method and use thereof |
06/13/2012 | CN102492022A Novel anti-senile dementia lead compound |
06/13/2012 | CN102492020A Pidotimod compound and new preparation method thereof |
06/13/2012 | CN102488892A Composite propolis composition used for treating unknown swine high-fever, and preparation method thereof |
06/13/2012 | CN102488891A Anti-tumor biological product and preparation method thereof |
06/13/2012 | CN102488890A Application of integrin blocker polypeptide AP25 in preparation of medicines for treating tumor |
06/13/2012 | CN102488889A Caspofungin preparation with low impurity content and preparation method and application thereof |
06/13/2012 | CN102488888A Medicinal composition containing echinocandin antifungal agent and preparation method and application thereof |
06/13/2012 | CN102488887A Echinocandin antifungal agent caspofungin containing medicinal composition, a preparation method and application thereof |
06/13/2012 | CN102488886A Caspofungin preparation with low impuritycontent and preparation method and application thereof |
06/13/2012 | CN102488885A Marine organism bacteria-removing liquid for pet |
06/13/2012 | CN102488884A Thymopoietin for large dosage injection and application thereof for treating severe hepatitis |
06/13/2012 | CN102488619A Device for continuously producing exenatide microspheres and method for controlling release rate of microspheres |
06/13/2012 | CN102210703B Dextran of polypeptide donkey-hide gelatin |
06/13/2012 | CN102161754B Functional modification method for branched polyethylene glycol (PEG) derivative |
06/13/2012 | CN101970639B Microorganism producing cyclic compound |
06/13/2012 | CN101962651B L-methionine gamma-lyase gene from deep sea metagenome and expression product thereof |
06/13/2012 | CN101948839B Antimicrobial peptide gene from pinctada fucata and application |
06/13/2012 | CN101875699B Fusion protein of human epidermal growth factor and metallothionein and preparation method and application thereof |
06/13/2012 | CN101837118B Compound chicken colibacillosis resisting veterinary drug preparation |
06/13/2012 | CN101817883B Housefly cecropin-human lysozyme fusion protein, and preparation method and application thereof |
06/13/2012 | CN101816790B Spray for treating radioactive xerostomia and preparation method thereof |
06/13/2012 | CN101810855B II-type collagen joint cartilage fluid and preparation method thereof |
06/13/2012 | CN101654679B Anti-tumor fusion gene and expression protein and application thereof |
06/13/2012 | CN101641117B Pharmaceutical composition |
06/13/2012 | CN101637454B Recombinant human bone morphogenetic protein-2 chitosan microballon and preparation method thereof |
06/13/2012 | CN101444618B Pharmaceutical preparation containing exenatide |
06/13/2012 | CN101280001B Preparation of human SDF-1 alpha, human SDF-1 alpha obtained therefrom and use thereof |
06/13/2012 | CN101146908B Novel protease, microorganism producing the same, and application thereof |
06/13/2012 | CN101014356B Oligopeptides for reducing elevated blood urea concentration |
06/12/2012 | WO2012082942A2 Neuropeptide analogs, compositions, and methods for treating pain |
06/12/2012 | USRE43472 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
06/12/2012 | USRE43467 Treatment of autoimmune disease |
06/12/2012 | US8198428 Identification of novel genes coding for small temporal RNAS |
06/12/2012 | US8198408 Method for preparing porous collagen matrices |
06/12/2012 | US8198407 Sequential protein isolation and purification schemes by affinity chromatography |
06/12/2012 | US8198406 Methods and compositions for inhibiting angiogenesis |
06/12/2012 | US8198405 Stabilized alpha helical peptides and uses thereof |
06/12/2012 | US8198402 Smoothened polypeptides and methods of use |
06/12/2012 | US8198401 Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritis |
06/12/2012 | US8198265 Regulation of T cell-mediated immunity by tryptophan |
06/12/2012 | US8198259 Treatment of neurological disorders by dsRNA administration |
06/12/2012 | US8198247 Process for and intermediates in the preparation of canfosfamide and its salts |
06/12/2012 | US8198246 Pharmaceutical composition of nanoparticles |
06/12/2012 | US8198245 Compositions and methods for soft tissue augmentation |
06/12/2012 | US8198244 Regulation of skin characteristics by DICKKOPF1 (DKK1) |
06/12/2012 | US8198243 Resuscitation fluid |
06/12/2012 | US8198242 Variants of C-type natriuretic peptide |
06/12/2012 | US8198241 Use of an agent that restores tissue perfusion and oxygenation |
06/12/2012 | US8198240 Methods for treatment of headaches by administration of oxytocin |
06/12/2012 | US8198239 Methods for treating wounds |
06/12/2012 | US8198238 Flowable carrier matrix and methods for delivering to a patient |
06/12/2012 | US8198237 Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof |
06/12/2012 | US8198236 Methods and compositions for the treatment of cancer |
06/12/2012 | US8198235 Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response |
06/12/2012 | US8198234 Methods of suppressing microglial activation |
06/12/2012 | US8198233 Synthetic peptides that enhance tight junction permeability |
06/12/2012 | US8198232 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
06/12/2012 | US8198231 Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains |
06/12/2012 | US8198078 Fucosyl transferase gene |
06/12/2012 | US8198077 Inducible small RNA expression constructs for targeted gene silencing |
06/12/2012 | US8198067 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
06/12/2012 | US8198062 Hydrolases, nucleic acids encoding them and methods for making and using them |
06/12/2012 | US8198042 Expression vector comprising nucleotide sequences coding g-protein-coupled receptor for use as tool in identifying modulator for prevention and treatment of viral infection; viricides |
06/12/2012 | US8198030 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use |
06/12/2012 | US8198020 Compositions and methods for enhancing phagocytosis or phagocyte activity |
06/12/2012 | US8197871 Composition for headache treatment |
06/12/2012 | US8197858 Use of calcitonin, SERMs such as raloxifene, testosterone, estrogen, calcimimetics such as cinacalcet, RANKL inhibitors such as denosumab, and bisphosphonates such as risedronate |
06/12/2012 | US8197826 Probiotic for enhancing immune response |
06/12/2012 | US8197824 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
06/12/2012 | US8197821 Human immunodeficiency virus integrase—Transportin—SR protein—protein interactions |
06/12/2012 | US8197820 HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination |
06/12/2012 | US8197813 Human antibodies that bind human TNFα |
06/12/2012 | US8197812 IL-1-like cytokine antibodies |
06/12/2012 | US8197808 Stable enzymatic preparations and methods of use thereof |
06/12/2012 | US8197807 Nucleotide sequences coding muscle specific integrin binding protein for use as tool in targeting cancer cells for destruction |
06/12/2012 | US8197802 Method for treating or inhibiting the formation of adhesions following surgery or injury |
06/12/2012 | US8197430 Method and system to remove cytokine inhibitor in patients |
06/12/2012 | CA2522146C Uptake of macromolecules |
06/12/2012 | CA2502385C Il-1 receptor based antagonists and methods of making and using |
06/12/2012 | CA2413251C Compositions and methods to improve the oral absorption of antimicrobial agents |
06/12/2012 | CA2363269C Dna vaccination for treatment of autoimmune disease |
06/12/2012 | CA2262756C A tumor necrosis factor related ligand |
06/12/2012 | CA2249746C Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |